Dorzolamide is a pharmaceutical raw material used as a carbonic anhydrase inhibitor. It is indicated for reducing elevated intraocular pressure in conditions such as glaucoma, with onset of action within three hours and a duration of at least eight hours when administered as an eye drop.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 120279-96-1
DORZOLAMIDE HYDROCHLORIDE
carbonic anhydrase inhibitor
Dorzolamide N-Sulfonamide Dimer
n.a
Cetrorelix
active pharmaceutical ingredient
Biapenem
carbapenem antibiotic active pharmaceutical ingredient
Icotinib Hydrochloride
active pharmaceutical ingredient
SAMIDORPHAN L-MALATE
active pharmaceutical ingredient
(4R,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide;hydrochloride
active pharmaceutical ingredient
N-[(4S,6S)-2-(Aminosulfonyl)-5,6-dihydro-6-methyl-7,7-dioxido-4H-thieno[2,3-b]thiopyran-4-yl]acetamide
pharmaceutical intermediate
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide
IAVUPMFITXYVAF-XPUUQOCRSA-N
CCN[C@H]1C[C@@H](S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C